Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

US Patent 11802162 · Granted Oct 31, 2023

Estimated economic value: $251,422,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD19/anti-CD38 common light chain bispecific antibodies2025
Glypican-3-binding fibronectin based scaffold molecules2025
Engineered CD25 polypeptides and uses thereof2025
Antibodies binding to ILT42025
Antibodies binding to ILT42025
Antibodies binding to ILT42025
Antibodies binding to ILT42025
Antibodies binding to ILT42025
Method for re-using test probe and reagents in biochemical assay based on interf2025
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Anti-interleukin-23 P19 antibodies and methods of use thereof2025